IMU-856

N/A

Report date: 2024/11/26 16:13:26
NME

Base Information

Drug NameIMU-856
Drug Alias NameIMU-856
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-6 modulators
TargetsNAD-dependent protein deacetylase sirtuin-6
Therapy Area/IndicationsCeliac Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImmunic IncImmunic
Inactive CompaniesN/A
Active IndicationsCeliac Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A